Close

Sagent Pharmaceuticals, Inc. (SGNT) Tops Q2 EPS by 10c

July 30, 2014 7:27 AM EDT
Get Alerts SGNT Hot Sheet
Price: $21.76 --0%

Today's EPS Names:
FSI, RELV, NEOM, More
Join SI Premium – FREE

Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT) reported Q2 EPS of $0.09, $0.10 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $69.2 million versus the consensus estimate of $67.14 million.

Sagent Pharmaceuticals, Inc. sees FY2014 revenue of $270-290 million, versus the consensus of $279.07 million.

For earnings history and earnings-related data on Sagent Pharmaceuticals, Inc. (SGNT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings